Related Experiment Video
Updated: May 26, 2026

11:00
Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry (UPLC-HRMS)
Published on: May 20, 2013
Stable isotope-resolved metabolomics and applications for drug development
Teresa W-M Fan1, Pawel K Lorkiewicz, Katherine Sellers
1Department of Chemistry, University of Louisville, KY 40292, USA. twmfan@gmail.com
Pharmacology & Therapeutics
|January 4, 2012
Summary
Stable isotope tracing combined with metabolomics (NMR and MS) reveals metabolic network dynamics in diseases. This approach enhances understanding of human metabolism for improved diagnostics and personalized therapeutics.
Area of Science:
- Biochemistry
- Systems Biology
- Analytical Chemistry
Background:
- Metabolomics, enabled by NMR and MS, is crucial for understanding metabolism's role in diseases like cancer.
- The metabolome reflects genomic and proteomic activity, playing a key role in homeostasis and disease pathology.
Purpose of the Study:
- To review the application of stable isotope tracers with metabolomics for analyzing metabolic network dynamics.
- To highlight advancements in atom-resolved isotope tracing for disease research and drug development.
Main Methods:
- Utilizing nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) for large-scale metabolome analysis.
- Employing stable isotope tracer-based metabolomic approaches to track metabolic pathways in vivo.
- Exploring metabolic tracer-based imaging technologies for visualizing metabolic processes.
Main Results:
- Atom-resolved isotope tracing via NMR and MS can identify metabolic reprogramming in diseases.
- This methodology aids in discovering novel drug targets and facilitates ADME studies.
- Metabolic tracer-based imaging offers in vivo visualization of metabolic functions.
Conclusions:
- Stable isotope-resolved metabolomics revolutionizes the understanding of complex human diseases and clinical diagnostics.
- This approach is vital for developing individualized therapeutics and predicting drug responses.
- Further development in biochemoinformatics is essential for clinical translation.

